Free Trial

Inogen (INGN) Competitors

Inogen logo
$6.67 -0.08 (-1.24%)
As of 10:19 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

INGN vs. BBNX, CBLL, DCTH, AVNS, BFLY, BVS, KIDS, NPCE, AXGN, and SMLR

Should you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Beta Bionics (BBNX), CeriBell (CBLL), Delcath Systems (DCTH), Avanos Medical (AVNS), Butterfly Network (BFLY), Bioventus (BVS), OrthoPediatrics (KIDS), NeuroPace (NPCE), AxoGen (AXGN), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Inogen vs.

Beta Bionics (NASDAQ:BBNX) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends.

Beta Bionics has higher earnings, but lower revenue than Inogen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beta Bionics$69.83M9.43N/AN/AN/A
Inogen$339.96M0.53-$102.45M-$1.15-5.80

89.9% of Inogen shares are owned by institutional investors. 1.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inogen received 384 more outperform votes than Beta Bionics when rated by MarketBeat users. Likewise, 68.78% of users gave Inogen an outperform vote while only 66.67% of users gave Beta Bionics an outperform vote.

CompanyUnderperformOutperform
Beta BionicsOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
InogenOutperform Votes
390
68.78%
Underperform Votes
177
31.22%

In the previous week, Inogen had 5 more articles in the media than Beta Bionics. MarketBeat recorded 5 mentions for Inogen and 0 mentions for Beta Bionics. Inogen's average media sentiment score of 0.96 beat Beta Bionics' score of 0.00 indicating that Inogen is being referred to more favorably in the news media.

Company Overall Sentiment
Beta Bionics Neutral
Inogen Positive

Beta Bionics currently has a consensus target price of $24.83, indicating a potential upside of 63.48%. Inogen has a consensus target price of $9.50, indicating a potential upside of 42.51%. Given Beta Bionics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Beta Bionics is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beta Bionics
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.78
Inogen
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Beta Bionics has a net margin of 0.00% compared to Inogen's net margin of -15.89%. Beta Bionics' return on equity of 0.00% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Beta BionicsN/A N/A N/A
Inogen -15.89%-27.38%-16.77%

Summary

Beta Bionics beats Inogen on 8 of the 15 factors compared between the two stocks.

Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INGN vs. The Competition

MetricInogenSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$179.23M$9.36B$5.31B$8.28B
Dividend YieldN/A1.27%5.20%4.10%
P/E Ratio-2.9620.5726.7319.58
Price / Sales0.5361.23387.44119.65
Price / CashN/A19.6738.2534.62
Price / Book0.765.086.744.47
Net Income-$102.45M$284.66M$3.23B$248.22M
7 Day Performance9.46%-2.46%-0.05%-1.32%
1 Month Performance-3.11%-1.27%8.51%10.73%
1 Year Performance-19.20%-21.11%18.25%8.40%

Inogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INGN
Inogen
4.1351 of 5 stars
$6.67
-1.2%
$9.50
+42.5%
-21.9%$179.23M$339.96M-2.961,030Analyst Upgrade
BBNX
Beta Bionics
N/A$15.10
+5.2%
$24.83
+64.5%
N/A$654.68M$69.83M0.00294Gap Up
CBLL
CeriBell
2.7212 of 5 stars
$17.83
-0.8%
$32.50
+82.3%
N/A$644.43M$71.54M0.00N/APositive News
Gap Up
DCTH
Delcath Systems
3.0952 of 5 stars
$18.10
+5.8%
$22.75
+25.7%
+105.7%$630.35M$53.85M-13.4160Positive News
Analyst Forecast
AVNS
Avanos Medical
2.6573 of 5 stars
$13.00
-0.8%
N/A-38.6%$601.17M$689.20M38.244,040Positive News
BFLY
Butterfly Network
2.6154 of 5 stars
$2.32
-1.3%
$4.00
+72.4%
+106.5%$573.71M$85.63M-5.04460Gap Up
BVS
Bioventus
3.147 of 5 stars
$6.93
+2.1%
$14.33
+106.8%
+3.3%$567.87M$567.70M-11.361,200Gap Up
KIDS
OrthoPediatrics
4.6057 of 5 stars
$22.95
-0.5%
$35.83
+56.1%
-36.2%$557.39M$212.45M-18.66200Positive News
NPCE
NeuroPace
1.4384 of 5 stars
$17.00
-2.8%
$15.00
-11.8%
+125.1%$556.80M$79.91M-17.00170High Trading Volume
AXGN
AxoGen
3.2587 of 5 stars
$11.76
-0.6%
$22.20
+88.8%
+76.5%$535.60M$194.52M-36.75450
SMLR
Semler Scientific
2.5506 of 5 stars
$43.27
+5.8%
$71.00
+64.1%
+92.4%$482.55M$56.29M8.81120News Coverage
Analyst Downgrade
Options Volume
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:INGN) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners